Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 34 studies | 30% ± 13% | |
| endothelial cell of lymphatic vessel | 22 studies | 46% ± 14% | |
| capillary endothelial cell | 14 studies | 32% ± 11% | |
| vein endothelial cell | 9 studies | 29% ± 8% | |
| endothelial cell of vascular tree | 7 studies | 26% ± 7% | |
| endothelial cell of artery | 4 studies | 25% ± 6% | |
| glomerular endothelial cell | 3 studies | 21% ± 6% |
Insufficient scRNA-seq data for expression of KANK3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 2173.80 | 652 / 653 | 100% | 9.29 | 602 / 605 |
| kidney | 100% | 1943.93 | 89 / 89 | 98% | 9.28 | 885 / 901 |
| prostate | 98% | 1029.25 | 241 / 245 | 98% | 4.02 | 492 / 502 |
| adrenal gland | 98% | 899.90 | 253 / 258 | 93% | 6.15 | 215 / 230 |
| esophagus | 92% | 1140.31 | 1334 / 1445 | 92% | 3.42 | 169 / 183 |
| brain | 84% | 613.69 | 2227 / 2642 | 99% | 5.63 | 699 / 705 |
| lung | 100% | 4357.86 | 578 / 578 | 83% | 2.90 | 963 / 1155 |
| bladder | 95% | 1000.43 | 20 / 21 | 86% | 2.52 | 431 / 504 |
| breast | 100% | 3398.50 | 459 / 459 | 80% | 2.81 | 894 / 1118 |
| uterus | 100% | 1510.85 | 170 / 170 | 79% | 2.21 | 361 / 459 |
| stomach | 93% | 626.42 | 334 / 359 | 85% | 3.69 | 243 / 286 |
| intestine | 95% | 829.82 | 916 / 966 | 79% | 2.43 | 414 / 527 |
| skin | 66% | 539.17 | 1185 / 1809 | 79% | 2.19 | 373 / 472 |
| pancreas | 31% | 147.16 | 103 / 328 | 96% | 4.51 | 171 / 178 |
| liver | 32% | 168.70 | 73 / 226 | 90% | 3.28 | 367 / 406 |
| ovary | 57% | 384.41 | 102 / 180 | 55% | 1.13 | 235 / 430 |
| adipose | 100% | 3318.12 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 4483.68 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.45 | 1 / 1 |
| heart | 98% | 1480.05 | 847 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 2.83 | 28 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 2.45 | 43 / 45 |
| muscle | 93% | 636.45 | 748 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 83% | 1164.74 | 1107 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 71% | 1.60 | 57 / 80 |
| peripheral blood | 3% | 11.78 | 26 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030837 | Biological process | negative regulation of actin filament polymerization |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005856 | Cellular component | cytoskeleton |
| Gene name | KANK3 |
| Protein name | KN motif and ankyrin repeat domain-containing protein 3 (Ankyrin repeat domain-containing protein 47) KN motif and ankyrin repeat domains 3 |
| Synonyms | ANKRD47 |
| Description | FUNCTION: May be involved in the control of cytoskeleton formation by regulating actin polymerization. |
| Accessions | Q6NY19 ENST00000330915.7 [Q6NY19-2] M0QZJ3 ENST00000595639.1 ENST00000593649.5 [Q6NY19-1] |
